16.79
price up icon1.63%   0.27
after-market 시간 외 거래: 16.79
loading
전일 마감가:
$16.52
열려 있는:
$16.67
하루 거래량:
661.27K
Relative Volume:
0.85
시가총액:
$1.37B
수익:
$288.00K
순이익/손실:
$-228.06M
주가수익비율:
-3.9506
EPS:
-4.25
순현금흐름:
$-168.82M
1주 성능:
-2.04%
1개월 성능:
+14.06%
6개월 성능:
-8.80%
1년 성능:
+16.03%
1일 변동 폭
Value
$16.57
$17.41
1주일 범위
Value
$15.96
$17.41
52주 변동 폭
Value
$9.90
$27.20

Viridian Therapeutics Inc Stock (VRDN) Company Profile

Name
명칭
Viridian Therapeutics Inc
Name
전화
617.272.4600
Name
주소
221 CRESCENT STREET, WALTHAM
Name
직원
143
Name
트위터
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
VRDN's Discussions on Twitter

VRDN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
VRDN
Viridian Therapeutics Inc
16.79 1.40B 288.00K -228.06M -168.82M -4.25
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.49 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.53 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.52 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
566.14 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.93 27.29B 3.81B -644.79M -669.77M -6.24

Viridian Therapeutics Inc Stock (VRDN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-12-19 다운그레이드 Wells Fargo Overweight → Equal Weight
2024-11-25 개시 TD Cowen Buy
2024-09-11 재확인 Needham Buy
2024-06-11 개시 Wolfe Research Outperform
2024-06-06 개시 Goldman Buy
2024-05-09 다운그레이드 B. Riley Securities Buy → Neutral
2024-05-09 다운그레이드 Ladenburg Thalmann Buy → Neutral
2023-06-14 개시 BTIG Research Buy
2023-06-14 재개 Credit Suisse Outperform
2023-05-30 개시 RBC Capital Mkts Outperform
2023-04-17 개시 Wells Fargo Overweight
2023-03-30 개시 Stifel Buy
2022-12-19 개시 Cowen Outperform
2022-12-19 개시 Needham Buy
2022-12-16 개시 Credit Suisse Outperform
2022-12-01 개시 H.C. Wainwright Buy
2022-06-23 개시 B. Riley Securities Buy
2021-11-18 개시 SVB Leerink Outperform
2021-10-12 개시 Evercore ISI Outperform
2021-01-25 개시 Ladenburg Thalmann Buy
모두보기

Viridian Therapeutics Inc 주식(VRDN)의 최신 뉴스

pulisher
03:12 AM

Teacher Retirement System of Texas Decreases Stock Holdings in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World

03:12 AM
pulisher
Jul 20, 2025

Is Viridian Therapeutics Inc. a good long term investmentTremendous portfolio expansion - Autocar Professional

Jul 20, 2025
pulisher
Jul 20, 2025

What drives Viridian Therapeutics Inc. stock priceSky-high return potential - Autocar Professional

Jul 20, 2025
pulisher
Jul 20, 2025

Viridian Therapeutics Inc. Stock Analysis and ForecastPhenomenal capital gains - Autocar Professional

Jul 20, 2025
pulisher
Jul 19, 2025

(VRDN) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Jul 19, 2025
pulisher
Jul 19, 2025

What analysts say about Viridian Therapeutics Inc. stockExtraordinary performance - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

Principal Financial Group Inc. Acquires 30,392 Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World

Jul 19, 2025
pulisher
Jul 17, 2025

Viridian Therapeutics’ Veligrotug Shows Durable Proptosis Response in Phase 3 TED Trial - MSN

Jul 17, 2025
pulisher
Jul 15, 2025

13 Best Low Priced Pharma Stocks to Buy Now - Insider Monkey

Jul 15, 2025
pulisher
Jul 15, 2025

Why Viridian Therapeutics Inc. stock attracts strong analyst attentionPortfolio Boosting Stock Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Viridian Therapeutics Inc. stock price move sharplyFast Moving Stock Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Viridian Therapeutics Inc. stock performs during market volatilitySafety First Trading Signals - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

Evercore Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Cuts Target Price to $38 - 富途牛牛

Jul 12, 2025
pulisher
Jul 12, 2025

Amalgamated Bank Has $34,000 Stake in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World

Jul 12, 2025
pulisher
Jul 11, 2025

Evercore ISI Lowers Viridian Therapeutics Price Target to $38 - AInvest

Jul 11, 2025
pulisher
Jul 10, 2025

Viridian Therapeutics Sees Relative Strength Rating Improve To 79 - MSN

Jul 10, 2025
pulisher
Jul 08, 2025

(VRDN) Investment Analysis - news.stocktradersdaily.com

Jul 08, 2025
pulisher
Jul 07, 2025

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Receives Average Rating of “Moderate Buy” from Analysts - Defense World

Jul 07, 2025
pulisher
Jul 03, 2025

Viridian Therapeutics: Fueling R&D Breakthroughs Through Strategic Equity Incentives - AInvest

Jul 03, 2025
pulisher
Jul 01, 2025

Is Viridian Therapeutics (NASDAQ:VRDN) A Risky Investment? - simplywall.st

Jul 01, 2025
pulisher
Jun 28, 2025

(VRDN) On The My Stocks Page - news.stocktradersdaily.com

Jun 28, 2025
pulisher
Jun 17, 2025

When (VRDN) Moves Investors should Listen - news.stocktradersdaily.com

Jun 17, 2025
pulisher
Jun 15, 2025

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Receives $37.56 Average Target Price from Analysts - Defense World

Jun 15, 2025
pulisher
Jun 13, 2025

Viridian Therapeutics’ SWOT analysis: promising TED treatment stock faces pivotal year - Investing.com

Jun 13, 2025
pulisher
Jun 11, 2025

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Shares Purchased by California State Teachers Retirement System - Defense World

Jun 11, 2025
pulisher
Jun 09, 2025

Viridian Therapeutics: The Song Remains The Same (NASDAQ:VRDN) - Seeking Alpha

Jun 09, 2025
pulisher
Jun 09, 2025

Transcript : Viridian Therapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 08 - MarketScreener

Jun 09, 2025
pulisher
Jun 07, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $2.22 Million Stake in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

Where are the Opportunities in (VRDN) - news.stocktradersdaily.com

Jun 05, 2025
pulisher
Jun 05, 2025

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | VRDN Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Jun 05, 2025
pulisher
Jun 04, 2025

Viridian Therapeutics shares fall as Q1 loss narrows, revenue beats By Investing.com - Investing.com Nigeria

Jun 04, 2025
pulisher
Jun 02, 2025

Ameriprise Financial Inc. Increases Stock Position in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World

Jun 02, 2025
pulisher
May 30, 2025

Viridian Therapeutics to Participate in Upcoming June 2025 Investor Conferences - BioSpace

May 30, 2025
pulisher
May 30, 2025

Viridian Therapeutics to Participate in Upcoming June Investor C - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Viridian Therapeutics to Participate in Upcoming June Investor Conferences - Business Wire

May 30, 2025
pulisher
May 29, 2025

Bank of America Corp DE Grows Position in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World

May 29, 2025
pulisher
May 27, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Buys 13,990 Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World

May 27, 2025
pulisher
May 27, 2025

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Stock Holdings Increased by Nuveen Asset Management LLC - Defense World

May 27, 2025
pulisher
May 27, 2025

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Shares Sold by Millennium Management LLC - Defense World

May 27, 2025
pulisher
May 23, 2025

Viridian reports long-term durability data, secures FDA designation for TED therapy - Eyes On Eyecare

May 23, 2025

Viridian Therapeutics Inc (VRDN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$21.69
price down icon 0.87%
$35.65
price up icon 0.17%
$102.78
price up icon 0.22%
$26.34
price up icon 0.53%
$108.91
price down icon 1.01%
biotechnology ONC
$291.93
price down icon 0.89%
자본화:     |  볼륨(24시간):